Abstract | Approximately one-third of patients with stroke exhibit persistent disability after the initial cerebrovascular episode, with motor impairments accounting for most poststroke disability. Exercise and training have long been used to restore motor function after stroke. Better training strategies and therapies to enhance the effects of these rehabilitative protocols are currently being developed for poststroke disability. The advancement of our understanding of the neuroplastic changes associated with poststroke motor impairment and the innate mechanisms of repair is crucial to this endeavor. Pharmaceutical, biological and electrophysiological treatments that augment neuroplasticity are being explored to further extend the boundaries of poststroke rehabilitation. Potential motor rehabilitation therapies, such as stem cell therapy, exogenous tissue engineering and brain-computer interface technologies, could be integral in helping patients with stroke regain motor control. As the methods for providing motor rehabilitation change, the primary goals of poststroke rehabilitation will be driven by the activity and quality of life needs of individual patients. This Review aims to provide a focused overview of neuroplasticity associated with poststroke motor impairment, and the latest experimental interventions being developed to manipulate neuroplasticity to enhance motor rehabilitation.
Introduction
Stroke is one of the most prevalent neurological con ditions worldwide, especially among the elderly.
1 This cerebrovascular disorder can cause a variety of symptoms and, in severe cases, may lead to death. Motor impair ment is one of the main disabilities associated with stroke, and where an environment has not been modified to accommodate a patient's functional limitations-for example, an absence of assistive devices to aid activities of daily living-their physical disability can substantially affect their quality of life.
The ability of training and physical activity to restore motor function after neural injury has long been appre ciated.
2 This observation has led to the establishment of rehabilitation and, notably, neurorehabilitation as clinical disciplines. Innate physiological and ana tomical plas ticity are important processes that underlie substantial gains in motor function after stroke, 2,3 and the combination of taskspecific training and general aerobic exercise is still the goldstandard treatment for poststroke rehabilita tion. Nevertheless, even with inten sive taskspecific training and physical activity, 15-30% of patients with stroke are permanently disabled. 4 As a result, research aiming to develop novel therapies that enhance neuroplasticity is currently being conducted to allow rehabilitation of these patients.
This area of research can be divided into three dif ferent arms, all of which are at relatively early stages of development. The first research arm relates to the study of the molecular and cellular mechanisms of normal move ment and the pathophysiological processes involved in poststroke paresis. An indepth understanding of the pathophysiological mechanisms of strokerelated paresis should lead to improvements in prognostic indicators of functional recovery, and more effective interventions to improve relearning of lost motor function than are cur rently available. [5] [6] [7] The second research arm is concerned with the development of pharmacological, biological and electrophysiological techniques that can augment tr aininginduced plasticity. 8 Both of these research arms aim to understand and enhance innate plasticity in the adult CNS, so that this neural process can be harnessed to aid poststroke rehabilitation.
2,9 Nevertheless, the degree of neuro plasticity that can occur in the adult brain is unknown, and the extensive neural reorganization that is observed in children after hemispherectomy 10,11 might not be in herently possible in adults.
12,13 Thus, the third research arm aims to utilize advances in biomedical and tissue engineering to promote functional recovery within the brain. Of note, attempts have been made to promote neural repair or replacement through use of innate or exogenous stem cells. 14, 15 Another prominent research avenue involves developing neuroprosthestics and braincomputer interface technologies to bypass injury via adap tive remote neuroplasticity, whereby part of the nervous system not originally dedicated to a particular task can be harnessed to provide the neural substrate that interacts with the neuro prosthesis or brain-computer device.
Socioeconomic, political and environmental factors need to be accounted for to fully address the complex issues associated with poststroke disability; 17 however, this review only focuses on the biological aspects of motor impairment after stroke, and the therapies being developed to restore motor function. unlike other reviews that have critically assessed the efficacy of post stroke treatments [18] [19] [20] or have focused on the contribu tions of neuroprotection and reperfusion to functional recovery, 21, 22 this article examines research aiming to enhance neuro plasticity after stroke. By assessment of the bio logical aspects of voluntary movement and neural plasticity that are being translated into the field of post stroke motor rehabilitation, we will highlight the most consistent and significant findings in the three arms of neuro rehabilitation research outlined above. In this article, special emphasis is given to studies of the patho physiology of poststroke paresis and the development of electrophysiological interventions that, when combined with customary trainingbased protocols, could aid motor rehabilitation in patients with stroke.
Current standard of care
Poststroke rehabilitation requires managing the dis ability and the chronic diseases that cause or accom pany the stroke. International guidelines have been developed on the basis of available data to promote best clinical practice in poststroke rehabilitation. [23] [24] [25] For the rehabilita tion of motor functions, dedicated rehabilita tive strat egies involving both physical and occupational therapy, among other treatments, are recommended. These treatments should preferably be undertaken in a specialized rehabilita tion unit. The guidelines also empha size the use of general aerobic exercise to regain physical endurance and intense taskdirected training to attain specific functional gains. Few comprehensive systematic reviews have evaluated the effectiveness of the various training techniques; 26 however, some of these thera pies are associ ated with marked improvements in motor function. For example, constraintinduced movement therapy-a regimen involving comfortable restraint of the non paretic limb in conjunction with 'forced' use of the paretic limb in activities of daily living, and in inten sive functional training-has been shown to be associ ated with an immediate decrease in disability rating scores in several metaanalyses. [27] [28] [29] By contrast, while individual trials have shown that body weightsupported treadmill training is associated with gains in motor function, 30 a sys tematic review of the literature relating to this approach came to a different conclusion. 31 Other techniques such as motor imagery, 32, 33 bilateral arm training 34 and robot assisted therapy 35, 36 might also improve motor function in patients with stroke, but the limited number of studies that have investigated these techniques precludes the formulation of meaningful guidelines for their use. 19, [37] [38] [39] A previous assumption that expensive and complex rehabilita tive methods could not be tested in randomized clinical trials has been proved incorrect by the imple mentation of several large, welldesigned clinical studies, and systematic reviews examining these trials have led to 
Poststroke physiology
Preclinical studies provide a means of exploring the cel lular and molecular pathophysiological processes associ ated with hemiparesis and/or stroke and the physiological processes underlying spontaneous recovery after experi mental brain injury. Studies in rodent models of stroke indicate that synaptogenesis increases substantially after experimental lesioning, and that dendrite number and shape are altered following infarction. Furthermore, both synaptogenesis and dendrite remodeling are associated with increases in neurological activity in the 'motor map' in the ipsilesional 43 and contralesional cerebral cortices. 44 Axonal reorganization has also been demon strated in rodent models of stroke, indicating that this process might be critical for spontaneous recovery after infarction. 45, 46 Data from animal models also support the use of taskspecific training and generalized aerobic exercise in poststroke rehabilitation, and show that these measures can activate molecular pathways-such as the upregulation of brainderived neurotrophic factor-that are important for neurogenesis as well as learning and memory. 47 Furthermore, taskspecific training in animal models of brain injury has been shown to induce changes in neural architecture, such as neural sprouting, synapto genesis and dendritic branching. [48] [49] [50] [51] [52] Anatomical and physiological changes are also known to occur with other types of motor training in rodents; for example, endur ance training increases metabolic demand and leads to angiogenesis, while skillspecific training induces synapto genesis and synaptic potentiation. 53 In humans, structural 54, 55 and metabolic brain imag ing [56] [57] [58] [59] and electrophysiological recording of the pri mary motor cortices [60] [61] [62] [63] have been used to document reorganiza tion of neural activity after stroke, with both ipsilesional and contralesional primary motor corti ces and the dorsal premotor cortex having been identi fied as areas that can undergo substantial poststroke neuro plasticity. evidence of this neural activity has led re searchers to investigate ways of predicting potential poststroke re covery. As a result of these investi gations, among patients with stroke, those with low contralesional primary motor cortex acti vity and evidence of ip silesional reviews motor cortexevoked potentials to transcranial magnetic stimulation maybe considered more likely to recover from stroke associated motor deficits than those who do not exhibit such phenomena. 58, 59, 64, 65 evidence of neural reorganization after stroke might also lead to the development of novel interventions that promote poststroke rehabilitation. 66 Studies using neuro imaging and neurophysiological techniques to identify changes in both metabolic activity 67 and anatomical connections 68 in the brain to investigate poststroke motor network dynamics indicate that nonprimary motor areas might contribute significantly to movement of the paretic limb after stroke. Transient disruption of activity in the contralesional premotor cortex through use of transcranial magnetic stimulation (TMS) has been shown to briefly alter hand movements in patients with stroke. 69 A limitation of neuroimaging techniques such as functional MrI or PeT is that although they can identify abnormal brain network activity after stroke, they are unable to determine whether such activity is inhibitory or excitatory in nature. 70 By contrast, intra cellular and extracellular electrophysiological recordings can identify poststroke changes in neural activity and determine whether these changes are inhibitory or excit atory. These approaches are limited, however, in relation to the number of networks that can be examined at any one time.
7, [67] [68] [69] 71 Through use of electrophysiological and neuro anatomical measures of neural activity in combination, thereby circumventing each technique's limitations, Stinear and colleagues 54 were able to predict whether patients with stroke were likely to regain any meaningful motor func tion. Patients with measurable motorevoked potentials (MePs) following TMS were deemed to have the best prognosis, regaining more motor func tionality than patients who did not exhibit such responses to TMS. Nevertheless, patients who lacked measurable MePs follow ing TMS could be subdivided into groups through measurement of white matter corticospinal integrity. using diffusion tensor imaging, the researchers measured func tional anisotropy of the ipsilesional and contralesional white matter tracts in the brain. Patients with functional anisotropy asymmetry ≥0.25-indicating significantly lower white matter tract integrity on the ipsi lesional side than on the contralesional side-were unlikely to show any meaningful recovery. In an extension to these find ings, electrophysiological evidence has indicated that corticospinal integrity might be the most important factor that influences poststroke recovery during the acute stage after stroke, whereas changes in local motor cortex circuitry might have the most influence on recovery potential 3 months after stroke. 62 Taken together, the research discussed above and other studies of compensatory or detrimental physiological processes associated with stroke have identified targets for novel interventional therapies to exploit; these thera pies will be discussed in the next section. Currently, these novel treatments are not customarily used in the clinic; however, the establishment of standards and guidelines for the study of poststroke functional recovery and its physiological correlates and markers, 72, 73 along with closer collaboration between basic and clinical scientists, 74 will probably promote the development of such therapies and lead to advances in neural repair and rehabilitation. As with any potential marker of poststroke recovery, it will be important to determine their relationship not only to quantitative functional outcomes, but also to measures of activities of daily living, participation and quality of life.
Strategies to promote plasticity

Pharmacological interventions
Pharmacological interventions that act on neuro transmitter systems might promote neural plasticity and could potentially enhance the effectiveness of post stroke motor therapies. Preclinical studies involving decerebrated cats or rodent models of brain injury 75, 76 have revealed that amphetamine treatment-through increased presynaptic release of dopamine and norepi nephrine, and inhibition of neurotransmitter reuptakemay have therapeutic effects following brain injury. Basic forms of motor training in humans can be enhanced by amphetamines, 77, 78 and these findings are consistent with the results of several small clinical trials of these drugs, which have shown that amphetamine treatment can decrease the level of motor impairment on tests such as the FuglMeyer score in patients with cerebral infarction. 79 enthusiasm for amphetamine treatment has waned, however, since larger trials of this therapy yielded mixed results: while four trials showed that ampheta mine treatment was associated with some rehabilitative benefit in patients with stroke, four other trials indicated that this treatment provided no benefit in this patient group. 80 Furthermore, a metaanalysis determined that, given the detrimental cardiovascular effects associated with amphetamines, 81 insufficient data existed to support the use of amphetamine therapy in the treatment of stroke. 82 Some investigators argue that the inconsistent results associated with this treatment might reflect the use of inappropriate animal models in preclinical studies, hetero geneity in brain lesions, use of inappropriate doses of amphetamines, and/or administration of such drugs at suboptimal time points during clinical studies. 80, 83 Future clinical trials will benefit from a reexamination of these issues and use of morehomogeneous strategies than were employed in previous trials (Figure 1) .
Complex behavioral factors such as motivation, which might not be easily translated from animal models to human patients, might account for inconsis tencies observed between clinical trial data and predic tions arising from the results of preclinical studies. This hypothesis might explain why inconsistent results have been associated with the use of levodopa in patients with stroke. 84, 85 Drugs that enhance the activity of the cholin er gic system, which is known to modulate neural activity throughout the cortex, are also being tested for their ability to enhance poststroke motor rehabilitation. In addition to their proven ability to enhance memory and execu tive function in patients with Alzheimer disease, these compounds have also been associated with improvements in sensorimotor function and overall activities of daily reviews living in case studies and small trials involving patients with stroke.
86-89 whether such enhancement of motor rehabilita tion is a direct consequence of improvements in motor learning or simply a reflection of the drugs' cogni tive effects is not fully understood. Nevertheless, further research into the use of pharmacotherapy in poststroke motor rehabilitation, and its potential impact on dis ability, is required before pharmacological treatment is employed in clinical care.
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Since the discovery of nerve growth factors 91 and the demonstration that neurogenesis could occur in the adult brain, 92 researchers have postulated that exogenous treatments that stimulate neurogenesis could improve recovery after stroke. [93] [94] [95] [96] [97] Preclinical studies have exam ined the ability of various growth factors, hormones and cytokines-including granulocyte colonystimulating factor, 98-100 erythropoietin [101] [102] [103] and brainderived neuro trophic factor [104] [105] [106] -to enhance motor rehabilitation after experimental ischemia, and these three proteins have all been found to improve both specific motor scores and more general behavioral scores in rodent models of stroke. Translation of these findings into clinical trials is just beginning, but although these three proteins could be promising future poststroke therapies, they are all associ ated with substantial safety concerns. For instance, while erythropoietin exhibited neuro protective effects in animal models, the largest clinical trial of erythro poietin therapy conducted to date actually showed that, compared with placebo, this treatment was associated with an increased risk of mortality in patients with acute ischemic stroke. 107 The observed increase in mortality risk associated with erythropoietin might have reflected an interaction between this agent and other stroke treatments administered during the trial. Indeed, the trial's investigators noted that a high number of patients involved in the study also received recombinant tissue plasminogen activator (rtPA), and rtPA may have caused hemorrhages in immature vascu lature that developed as a result of erythropoietin therapy. erythropoietin might have also interacted detrimentally with common strokerelated comorbidities such as hyper tension and diabetes, and such interactions may not have been anticipated in preclinical experiments.
107,108
Nervous system stimulation Therapies that directly stimulate the PNS or CNS may enhance neuroplasticity during poststroke rehabilitation, and might help patients with stroke overcome their motor impairments. For example, devices that provide electrical stimulation to peripheral nerves and muscles might assist stroke patients with hemiparesis move their affected limbs. Furthermore, PNS stimulation can influence the CNS via afferent pathways, and some PNS stimulation protocols have been designed specifically to induce cor tical plasticity. For example, repetitive peripheral nerve stimulation has been shown to improve both strength in paretic limbs and learning of a sequential fingertapping sequence in patients with stroke (Figure 1) . [109] [110] [111] [112] [113] [114] [115] [116] [117] Stimulation of the CNS, specifically the primary motor cortex (M1), might directly enhance motor rehabilitation after stroke. TMS and direct current stimulation (Figure 1 ) offer noninvasive approaches of stimulating the cortical surface of the brain, while epidural electrodes can be sur gically implanted to stimulate the motor cortex directly.
8,118
Since 'normal' limb movement is accompanied by a tran sient increase in excitability in the corticospinal tract, numerous research groups have investigated the use of reviews electrical stimulation-either applied transcranially [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] or through implanted epi dural electrodes [131] [132] [133] -to exo genously increase the excitability of the strokeaffected ipsilesional M1 in order to improve function. Most studies of ipsilesional M1 stimulation have demonstrated an improvement in at least one motor ability, such as an active range of motion, or have demonstrated improved performance on specific functional rehabilitation tests. Interventions that stimulate the M1 are still at the experi mental stage and, consequently, have not been subjected to large, wellcontrolled clinical trials that test their effects on patient activity and/or participation. Nevertheless, a doubleblind, controlled, multi center clinical trial that aims to investigate the efficacy of transcranial direct current stimulation combined with physical therapy to enhance rehabilitation after stroke is under way. 134 The exact mechanisms of action of these techniques are under investigation, 135 but improvements in motor func tion that are associated with stimulation of the CNS might occur as a direct result of changes in synaptic activity and gene expression, and increases in neurotransmitter, receptor and neuro trophin levels. [136] [137] [138] [139] Furthermore, the efficacy of these techniques seems to be highly dependent on the intensity, duration and frequency of the electrical stimulation, as well as on the area of the brain being stimulated. 139 Metabolic brain imaging often reveals abnormally high levels of activity in the contralateral motor cortex of patients with stroke. [140] [141] [142] [143] The functional role of this activity is unknown; however, electrophysiological data indicate that interhemispheric inhibition of the ipsi lesional M1 by the contralesional M1 is abnormally persistent during movement of the paretic hand. 63, 144 Together, these data support the hypothesis that inter hemispheric competition 145 might be a factor that influences motor rehabilitation after stroke. Thus, the contralesional M1 has become a major target for inter ventional therapy for poststroke rehabilitation (Figure 1 ). Several studies have demonstrated small but significant improvements in both simple and more complex tests of hand function in patients with subacute or chronic stroke who have undergone stimulation to decrease excit ability in the contralesional M1, 122, 128, [146] [147] [148] [149] [150] [151] [152] although a recent trial has shown contradictory results. 153 The combination of PNS and CNS stimulation to promote neuroplasticity has been investigated in pre clinical studies and in a small trial involving patients with stroke, [154] [155] [156] [157] [158] and promising results for this approach have been reported. In one study of patients with stroke, repetitive lowintensity peripheral stimulation of the paretic limb with subsequent transcranial direct current stimulation of the affected primary motor cortex resulted in improved procedural learning of a fingertapping sequence. 154 Furthermore, paired associative stimulation, whereby peripheral stimulation and central stimulation are timed to coincide in such a way as to induce spike timingdependent plasticity, has been used to promote motor recovery in a rodent model of stroke, 155 but this technique has only demonstrated electro physiological effects in patients with stroke to date. 156, 157 Taken together, most early clinical studies of nervous system stimulation (reviewed above) have demonstrated some positive effects on poststroke motor rehabilita tion. Nevertheless, the overall effect sizes observed in these studies have not been significantly greater than those demonstrated with behavioral therapy alone. 118 To address the issue of treatment efficacy for nervous system stimulation, new trials are being designed that extend the duration of treatment, combine complemen tary methods of stimulation, and identify patients most likely to benefit from each intervention. Treatment effect sizes may improve when patients with similar stroke related impairments are enrolled in large studies and when the most effective stimulation protocol and clini cally relevant functional outcome measures are identi fied. 118 Nevertheless, our understanding of the dynamics of inhibition and excitation within the motor system, upon which stimulation studies are based, is still incom plete. Thus, a better understanding of the connectivity and interactions within the motor system might lead to moreefficacious stimulation protocols.
7,159,160 Such therapies will all need to be assessed with regard to their outcomes on patient activity and quality of life before becoming part of clinical practice.
Novel treatments stem cells
Above, we have reviewed the areas of research that aim to enhance innate repair mechanisms within the CNS after stroke, but there might be a limit to how much endo genous regeneration can be augmented and supported. These issues might be circumvented through replacement of damaged neural tissue by use of artificial or exogenous materials to improve neural regrowth, or bypassing strokerelated impairment by developing prosthetics that are directly con nected to the CNS (for example, an orthosis that moves a paralyzed limb by taking instructions directly from the brain). Preclinical success with neural stem cell therapy, despite limited understanding of the mechanisms of action, dosing and possible adverse effects, 161 has led to the first clinical trial of such therapy for poststroke hemi paresis, which is being conducted in the uK. 162 In preclinical studies, both humanderived and rodent derived stem cells were transplanted into rodents with experimentally induced stroke, where they migrated to the location of the lesion and developed into electrophysi ologically and anatomically mature neurons. (Figure 1) . One area of preclinical research attempting to improve the success of this treatment approach is focusing on how exogenous scaffolding or modulation of the local environ ment might improve the proliferation and growth of stem cells. 15, 163, 164 By providing an artificial extracellular envi ronment that promotes appropriate cell growth, nano technology could have a role in improving and modifying stem cell therapy (Figure 1) . 165 
Neuroprosthetics
Prosthetics and orthotics have generally been designed to provide support for a weak limb, and only indirect effects on function have usually been associated with reviews these kinds of devices. However, if orthotics could be developed that enable patients with stroke to achieve their intended motor goals, such as walking unaided, these devices could serve a more functional purpose (Figure 1 ). research into both invasive and noninvasive brain-computer and nerve-computer interfaces has shown that patients with stroke can control exogenous systems through training. [166] [167] [168] In one study, magneto encephalography was used to record the sensorimotor μ rhythm over the affected M1 region of patients with chronic hemiparesis. These patients success fully learned to use motor imagery to control the mu rhythm and, through the brain-computer interface, to control an orthotic device that opened and closed their paralyzed hand (Figure 2) . 167 In addition, a single case report has shown that an eeG brain-computer interface enabled a patient with chronic stroke to control functional electri cal stimulation of her paretic limb, leading to voluntary finger extension. 169 Interestingly, the neuroprosthetic methods highlighted above are being explored not only as a means to bypass injury, but also as a means by which to encourage training and practice; for instance, robotic devices have been used as training tools to promote neuro plasticity (Figure 1 ). 170 
Future therapies
Motor rehabilitation after stroke will no doubt benefit from continued advances in basic systems neuro science. For example, the development of optogenetics 171, 172 and noninvasive ultrasound 173 could offer new ways of studying and guiding neural plasticity with increasing accuracy. Furthermore, understanding how genetic poly morphisms affect the therapeutic potential of various training and stimulation protocols 135, 174, 175 could allow molecular and electrophysiological inter ventions to be combined synergistically to improve cortico spinal tract repair after stroke. These nascent areas of rehabilitative research, however, all require significant investment to bring them into clinical practice.
Defining rehabilitation goals
As research into poststroke neuroplasticity and motor rehabilitation evolves, assessment of the motor out comes that benefit patient activity and participation, 176 and the patients own rehabilitative goals, will be impor tant. 177 we should anticipate that interventions that restore body functions and those that increase par ticipation might not be viewed equally by patients, and that patient satisfaction may itself depend on a balance between restoring body functions and increasing par ticipation. In the case of interventions that are associ ated with marked success in clinical studies, patients may not always feel that the benefits of such treatments are worth the sacrifices and effort required to see such rewards. 178 Thus, future clinical research into poststroke rehabilita tion should employ assessments of quality of life and patient satisfaction. 179, 180 Defining the specific purpose of rehabilitative treat ments, both before such therapies are tested in trials and once they are used clinically, is important, since the goals of one particular intervention may actually conflict with the goals of a different intervention. For example, train ing protocols that focus on relearning how to perform a particular motor task in the same manner to how it was carried out before the stroke might be substantially different from treatments that aim to teach the patient how to execute a task through a set of adaptive strat egies. 181 Furthermore, the choice of one strategy over another approach might determine which aspect of neuro plasticity is enhanced, and could limit the efficacy of other forms of plasticity. we will probably find that patient preferences as well as genetic and social factors will affect each patient's responses to rehabilitative thera pies; thus, customization of poststroke therapies will probably be required in the future.
182,183
Conclusions
Motor rehabilitation after stroke continues to be an area in need of substantial financial and scientific investment. Our understanding of the mechanisms underlying stroke induced paralysis is increasing and, with this knowledge, our ability to modulate the neural structures affected by reviews stroke and to stimulate neuro plasticity is improving. Advances in technology are aiding the development of therapies that can augment innate repair mechanisms or, even, bypass such processes, thereby provid ing alternate methods to carry out tasks of daily living. As the number of methods for modulating strokerelated physiological processes increase, so must the emphasis on measuring both functional outcomes and quality of life in patients. Poststroke neurorehabilitation is evolving into a field dom inated by multidisciplinary interactions and collaborations, as therapists, molecular biologists, engineers, physiologists, physicians and patients work together towards the goal of improving the quality of life of patients with stroke.
Review criteria
The authors' personal collections of stroke rehabilitation literature were reviewed for seminal articles in this field. These collections were augmented by searches of the PubMed database using the following terms: "motor rehabilitation", "stroke rehabilitation" and "neurorehabilitation". References from these articles were searched for further relevant material. The US National Guidelines Clearinghouse (http:// www.guideline.gov/) and the US NIH clinical trials database (http://www.clinicaltrials.gov/) were also searched with the same terms to find the most recent guidelines regarding poststroke rehabilitation. 
